And as we learn of another 440 legacy Organon people let go tonight in Oss (Netherlands), on the continent -- we reflect on just how hard the world has been on pharma's rank and file employees -- these past seven years.
From an Anon. commenter (much below -- just offered, in a June 2013 post): . . .Another blow for the MSD site in Oss. Today 440 employees of the Development Center were told they will lose their jobs. So much for the R&D activities of what once was the most innovative pharma company in the Netherlands. . . . Truly sad.
To a person, honest, hard working, brilliant, devoted people -- with families and lives -- now forever altered.
Let's just get it over with, then: here's the news item -- from NJBiz.com:
. . . .As part of its effort, the firm [Jones Lang LaSalle] said it will focus on bringing another life science or research company to the 12-building, 88-acre campus on Morris Avenue. Daniel Loughlin, JLL's lead broker in New Jersey, said in a prepared statement that it's looking for a user "who can maximize existing investments made in the property, (including) move-in ready research, innovation and commercialization space."
The site has effectively been on the selling block since last fall when Merck said it would consolidate its operations and move its global headquarters to its Kenilworth campus from the Whitehouse Station section of Readington. The decision came after the pharmaceutical giant first said it would move its headquarters to Summit, but changed course. . . .
Be kind to one another. Unless the other is a. . . troll, of course. Heh.
No comments:
Post a Comment